MYC and diffuse large B-cell lymphoma: Cases with IG::MYC are significantly associated with worse progression-free survival (PFS) and overall survival (OS), particularly within the first two years of diagnosis, while those with non-IG::MYC showed no significant difference in both PFS and OS from DLBCL without MYC translocation [7, 9].